The secondary research process involved comprehensive analysis of regulatory databases, peer-reviewed scientific journals, industry publications, and authoritative health and agriculture organizations. Key sources included the US Food & Drug Administration (FDA), Drug Enforcement Administration (DEA), National Institute on Drug Abuse (NIDA), National Institutes of Health (NIH), National Center for Biotechnology Information (NCBI/PubMed), Substance Abuse and Mental Health Services Administration (SAMHSA), Centers for Disease Control and Prevention (CDC), European Monitoring Centre for Drugs and Drug Addiction (EMCDDA), Health Canada, Cannabis Act Regulatory Framework, United Nations Office on Drugs and Crime (UNODC), World Health Organization (WHO) Expert Committee on Drug Dependence, National Cannabis Industry Association (NCIA), Marijuana Policy Project (MPP), Drug Policy Alliance, state-level cannabis regulatory authorities (California Bureau of Cannabis Control, Colorado Marijuana Enforcement Division), Statistics Canada, US Census Bureau, Bureau of Economic Analysis, and national health ministry reports from key markets including Germany's Federal Institute for Drugs and Medical Devices (BfArM), Netherlands' Office of Medicinal Cannabis, Australia's Therapeutic Goods Administration (TGA), and Thailand's Food and Drug Administration.
For THC edibles, CBD edibles, hybrid formulations, and product categories like gummies, chocolates, beverages, baked goods, and savory snacks, these sources were used to gather regulatory approval data, legalization timelines, consumption statistics, clinical safety studies, demographic trends, and market landscape analysis.